An identifiable subject or patient The type of surgical treatment the patient was undergone An identifiable reporting source All related adverse events All medications used Follow-up of SAE/ADEs that occur during the study will continue until satisfactory resolution or stabilization, with a maximum of six months, upon judgment of the investigator. The coordinating investigator may request that certain adverse events to be followed until resolution.